Physician profile
Michael Friedman
NPI 1932161056
$5,997.02
in general payments reported to CMS, 2019-2025
25 companies · $138 in 2025
The $138 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,689 · 2021: $176 · 2022: $226 · 2023: $406 · 2024: $363 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $906.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $906.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Incorporated | $4,160.00 | 2019 | |
| Inspire Medical Systems, INC. | $718.77 | 2019-2024 | Inspire |
| Acclarent, INC | $251.40 | 2019-2023 | Acclarent Aera |
| Neurent Medical Limited | $249.35 | 2024-2025 | Neuromark Radiofrequency Console, Neuromark Device, Neuromark System |
| Glaxosmithkline, LLC. | $182.36 | 2021-2025 | Nucala |
| Smith+Nephew, INC. | $51.31 | 2023 | Tula, Coblation |
| Stryker Corporation | $48.29 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $43.40 | 2021 | |
| Philips North America LLC | $32.05 | 2025 | Patient Interface Software |
| Merck Sharp & Dohme LLC | $24.11 | 2023 | |
| Fisher & Paykel Healthcare INC | $23.56 | 2024 | Fisher & Paykel Healthcare |
| Medtronic, INC. | $23.19 | 2023 | Bravo |
| Hologic Sales and Service, LLC | $22.66 | 2024 | Coolseal Generator |
| Cook Medical LLC | $22.55 | 2019 | |
| Hospira, INC. | $22.19 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $21.36 | 2025 | Mounjaro |
| Hikma Pharmaceuticals USA | $19.70 | 2023 | Ryaltris |
| Jazz Pharmaceuticals INC. | $18.05 | 2021 | |
| Optinose US, INC. | $16.61 | 2019 | |
| Harmony Biosciences LLC | $16.18 | 2023 | Wakix |
| Olympus America INC. | $15.10 | 2024 | Olympus |
| Lucid Diagnostics INC. | $14.83 | 2023 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Friedman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.